Gland Pharma Ltd — Quarterly Results & Earnings

₹1696.10

+0.56%

Profit Growth YoY12.32%Latest quarter

Sales Growth YoY5.77%Latest quarter

Sales CAGR 5Y16.36%5 year compound

Profit CAGR 5Y-1.69%5 year compound

📋

Quarterly Performance

YoY Profit Growth+12.32%

✅ Strong growth

YoY Sales Growth+5.77%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

28.28%

EPS Growth 5Y

-2.89%

Interest Coverage

Higher = safer debt servicing

24.88

ROE

7.81%

ROCE

11.89%

💡

Growth Analysis

Gland Pharma Ltd reported YoY profit growth of 12.32% and revenue growth of 5.77% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 16.36% and profits at -1.69% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Gland Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.